Standout Papers

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer 2021 2026 2022 20241.4k
  1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (2021)
    Oliver Sartor, Johann S. de Bono et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
2 intermediate papers

Works of Germo Gericke being referenced

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout

Author Peers

Author Last Decade Papers Cites
Germo Gericke 535 1060 65 980 6 1.5k
Nitin Vaishampayan 542 1081 44 988 12 1.6k
Euloge Kpamegan 572 1259 39 1010 11 1.7k
Chandler H. Park 570 1083 33 989 20 1.5k
Sue Ping Thang 544 1238 97 1183 25 1.6k
Ingo Klette 437 802 39 1030 15 1.3k
Mark Scalzo 389 1034 14 1061 9 1.3k
Aravind Ravi Kumar 456 1168 15 1155 22 1.5k
Hans-Jürgen Wester 510 1069 123 1260 23 2.1k
Christiane Schuchardt 810 824 148 1269 31 1.7k
Stefan Kürpig 452 1012 19 1122 23 1.3k

All Works

Loading papers...

Rankless by CCL
2026